Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Prostate cancer (Triptorelin - Prostate cancer)

Records returned : 10 (on 29 May 2025 at 12:55:00). Return to search results for ' Prostate cancer '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Triptorelin

Drug:

Triptorelin

Indication :

Prostate cancer

Status :

Blue

Formulations :

Injection

Restrictions / Comments:

Important

Primary Care prescribing appropriate on recommendation from the specialist team.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Bicalutamide

Drug:

Bicalutamide

Indication :

Prostate cancer

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

To be prescribed on recommendation from a specialist.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Cyproterone acetate

Drug:

Cyproterone acetate

Indication :

Prostate cancer

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Degarelix

Drug:

Degarelix

Indication :

Prostate cancer

Status :

Blue

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Important

Initiation and 1st month supply by the specialist team before any request for primary care prescribing.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Diethylstilbestrol

Drug:

Diethylstilbestrol

Indication :

Prostate cancer

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Initiation and 1st month supply by the specialist team before any request for primary care prescribing.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Goserelin acetate

Drug:

Goserelin acetate

Indication :

Prostate cancer

Status :

Blue

Formulations :

Implant

Restrictions / Comments:

Important

Primary Care prescribing appropriate on recommendation from the specialist team.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Leuprorelin acetate

Drug:

Leuprorelin acetate

Indication :

Prostate cancer

Status :

Blue

Formulations :

Subcutaneous injection (sc)

Restrictions / Comments:

Important

Primary Care prescribing appropriate on recommendation from the specialist team.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

8. Medroxyprogesterone acetate

Drug:

Medroxyprogesterone acetate

Indication :

Prostate cancer

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Off-label use. Hot flushes caused by long-term androgen suppression in men with prostate cancer

1st month supply from specialist team before request for primary care prescribing

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

9. Relugolix

Drug:

Relugolix

Indication :

Prostate cancer

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

Specialist to prescribe at least 1 month treatment, prior to transfer of care

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NICE

10. Tamoxifen citrate

Drug:

Tamoxifen citrate

Indication :

Prostate cancer

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Important

Off-label use. Gynaecomastia prevention in men undergoing long-term bicalutamide treatment, if radiotherapy unsuccessful

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC